Endothelial to Mesenchymal Transition via Transforming Growth Factor-β1/Smad Activation Is Associated with Portal Venous Stenosis in Idiopathic Portal Hypertension
- 31 August 2009
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 175 (2), 616-626
- https://doi.org/10.2353/ajpath.2009.081061
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Cholangiocytes with Mesenchymal Features Contribute to Progressive Hepatic Fibrosis of the Polycystic Kidney RatThe American Journal of Pathology, 2007
- Does transformation of microvascular endothelial cells into myofibroblasts play a key role in the etiology and pathology of fibrotic disease?Medical Hypotheses, 2007
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in ratsGut, 2007
- Emerging insights into Transforming growth factor Smad signal in hepatic fibrogenesisGut, 2007
- Pathological study of idiopathic portal hypertension with an emphasis on cause of death based on records of Annuals of Pathological Autopsy Cases in JapanJournal of Gastroenterology and Hepatology, 2007
- BMP‐7 functions as a novel hormone to facilitate liver regenerationThe FASEB Journal, 2006
- Idiopathic Portal Hypertension and Its PathologySeminars in Liver Disease, 2002
- Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor β‐1Journal of Gastroenterology and Hepatology, 2002
- Histopathology of the liver in non‐cirrhotic portal hypertension of unknown aetiologyHistopathology, 1996